Europe Oligonucleotide Synthesis Market Size and YoY Growth (2025-2032)

Free

in USD Million and Precentage

Rising Demand for Targeted Therapies to Drive Europe Oligonucleotide Synthesis Market

Published by MMR Statistics Reserch Team, November 2025

Strengthening demand for precision genetic tools is shaping across Europe as healthcare systems intensify their focus on targeted therapies and molecular diagnostics. In 2025, the Europe Oligonucleotide Synthesis Market is estimated to reach USD 2,708.63 million with a YoY of 13.03%, supported by expanding use of oligonucleotides in personalised medicine, qPCR workflows, and RNA-based research. Increasing deployment of automated synthesis platforms enables higher accuracy and throughput for customised sequences used in clinical and preclinical programs. The forecast period highlights Europe Oligonucleotide Synthesis Market projected values of USD 3,067.04 million in 2026 and a YoY of 13.23%, moving to USD 3,966.75 million by 2028 alongside a YoY of 13.93%. Growing investment in RNA therapeutics, rising prevalence of genetic disorders, and greater outsourcing to specialised manufacturers are creating opportunities across the region.

OTHER STATISTICS ON TOPIC

Genetic Synthesis

More statistics on Genetic Synthesis

Download

Information

Unit

in USD Million and Precentage

Region

Europe

Time Period

2025-2032

Source Name

Maximize Market Research Pvt. Ltd

Source Link

http://www.maximizemarketresearch.com

Publisher Name

Maximize Market Research Pvt. Ltd

Publisher Link

http://www.maximizemarketresearch.com

Related Topics

  • Blood Substitutes

    Access global statistics, survey data, and industry insights on blood substitutes from MMR Statistics.

  • Lab Equipment

    Access revenue, growth data, and essential market statistics on lab equipment from MMR Statistics.

Related reports

Market Research Reports on Genetic Synthesis

Explore published research tied to this statistic's topic. Open the featured edition or jump into another region without leaving the page.

Subscriptions

Stay ahead of Genetic Synthesis with tailored access

Sample free-tier statistics or unlock premium coverage for this topic with team-friendly usage rights.

Discover

Try free-tier statistics before committing to a plan.

Professional

Unlock premium coverage across this topic with analyst support.

Contact our team

Need a bespoke deep-dive on Genetic Synthesis?

Tell us about your KPIs and coverage priorities. We can tailor a briefing, share methodology notes, or build a custom dataset that complements the reports and statistics you are browsing.